Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 59,077 | 80,542 | 47,083 | 43,766 | 72,178 |
| Cost of Goods | 13,921 | 29,097 | 10,658 | 10,728 | 24,323 |
| Gross Profit | 45,156 | 51,445 | 36,425 | 33,038 | 47,855 |
| Operating Expenses | 32,712 | 29,463 | 39,262 | 36,065 | 33,380 |
| Operating Income | 13,365 | 22,079 | -2,179 | -2,299 | 14,798 |
| Interest Expense | 2,621 | 3,100 | 3,372 | 3,359 | 3,354 |
| Other Income | 1,494 | 1,629 | 1,400 | 1,063 | 1,360 |
| Pre-tax Income | 12,238 | 20,608 | -4,151 | -4,595 | 12,804 |
| Income Tax | -7,067 | 291 | 378 | 220 | 536 |
| Net Income Continuous | 19,305 | 20,317 | -4,529 | -4,815 | 12,268 |
| Net Income | $19,305 | $20,317 | $-4,529 | $-4,815 | $12,268 |
| EPS Basic Total Ops | 0.40 | 0.41 | -0.09 | -0.10 | 0.26 |
| EPS Basic Continuous Ops | 0.40 | 0.41 | -0.09 | -0.10 | 0.26 |
| EPS Diluted Total Ops | 0.40 | 0.41 | -0.09 | -0.10 | 0.25 |
| EPS Diluted Continuous Ops | 0.40 | 0.41 | -0.09 | -0.10 | 0.26 |
| EPS Diluted Before Non-Recurring Items | 0.39 | 0.41 | -0.09 | N/A | N/A |
| EBITDA(a) | $16,206 | $24,957 | $729 | $598 | $17,687 |